Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fibrosis × Hyperbaric Oxygenation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Sarcoma 2 Radiation Injuries 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Gliosarcoma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Radiation Pneumonitis 1 Radiation Fibrosis Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Myelodysplastic Syndromes 1 Lymphoma 1 Lymphedema 1 Laryngeal Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Fibrosis 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1

Interventions

Blood Specimen Collection 8 Magnetic Resonance Spectroscopy 5 Pentoxifylline 4 Liver Transplantation 4 Tenofovir 3 Specimen Handling 3 High-Energy Shock Waves 3 Tocopherols 2 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 peginterferon alfa-2a 1 navitoclax 1 maltodextrin 1 hepatitis B hyperimmune globulin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 adefovir dipivoxil 1 Viusid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01822405 2013-04-02

ORT-OXI-2009

Hospital Universitario de Canarias

Phase 2 Unknown

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡